Cefpodoxime (Cefpodoxime Proxetil) Dosage and Treatment Duration in Adults
The typical dosage of cefpodoxime for adults is 200 mg twice daily, with treatment duration ranging from 5-14 days depending on the type of infection being treated. 1
Standard Adult Dosing Regimens
Respiratory Tract Infections:
Skin and Skin Structure Infections:
- 400 mg twice daily for 7-14 days 1
Urinary Tract Infections:
Dosage Adjustments
Renal Impairment:
Hepatic Impairment:
- No dosage adjustment required for patients with cirrhosis (with or without ascites) 1
Pharmacokinetic Considerations
- Cefpodoxime proxetil is a prodrug that is converted in vivo to the active cephalosporin cefpodoxime 4
- Can be administered without regard to food 1
- The drug is primarily excreted unchanged by the kidneys 4
- Has a broad spectrum of activity against common respiratory pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 4, 3
Clinical Applications
Cefpodoxime is a third-generation cephalosporin recommended as one of the first-line antibiotics for:
In sinusitis treatment, cefpodoxime has been shown to be effective in 5-day regimens, which is shorter than traditional 10-day courses of some other antibiotics 5
Comparative Efficacy
- Studies have shown cefpodoxime to be as effective as amoxicillin-clavulanate in the treatment of respiratory infections 2
- In a study comparing cefpodoxime with trimethoprim-sulfamethoxazole for uncomplicated cystitis, cefpodoxime demonstrated excellent clinical and microbiological cure rates 2
Common Side Effects
- Primarily gastrointestinal disturbances (diarrhea most common) 6
- Skin rashes 6
- Side effect profile is consistent with other oral cephalosporins 6
Important Considerations
- For respiratory infections, cefpodoxime is particularly useful when there are concerns about resistant pathogens 2
- The twice-daily dosing schedule may improve patient compliance compared to medications requiring more frequent administration 4
- In areas with high prevalence of penicillin-resistant Streptococcus pneumoniae, cefpodoxime may be preferred over amoxicillin for respiratory infections 2
Remember that antimicrobial resistance patterns vary by region, so local susceptibility patterns should be considered when selecting an antibiotic regimen 2.